Fri 23'rd Feb 2018
VistaGen Therapeutics Inc Stock Analysis
Technical stock analysis for Fri 23'rd Feb 2018
|Shorts||0.82% ( 2018-01-31 )|
VistaGen Therapeutics Inc lies in the lower part of a very wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $0.94 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 11.47% during the next 3 months and, with 90% probability hold a price between $1.05 and $2.48 at the end of this period.
A buy signal was issued from a pivot bottom point on Wednesday February 21, 2018, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. VistaGen Therapeutics Inc holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $1.22 and $1.26. A break-up above any of these levels will issue buy signals. VistaGen Therapeutics Inc gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's".
Relative Strength Index (RSI)
RSI14 is 52 and the stock is currently not being overbought or oversold
Support & Resistance
VistaGen Therapeutics Inc finds support from accumulated volume at $1.17. On the upside the stock meets some resistance just above today's level from accumulated volume at $1.19, $1.22 and $1.43.
The stock is about to test the resistance from accumulated volume at $1.19 and this may cause the stock to take a minor break or get into a more sideways move for a few days.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.04 between high and low, or 3.45%. For the last week, the stock has had a daily average volatility of 4.59%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
The VistaGen Therapeutics Inc stock holds several negative signals and despite the positive trend we believe VistaGen Therapeutics Inc will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
Trade VTGN CFDs with Plus500
Your capital is at risk.
Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).
Access these features
Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder